Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DRB is a nucleoside analog that inhibits several carboxyl-terminal domain (CTD) kinases including casein kinase II (IC50 range of 4-10 μM)
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 34.00 | |
25 mg | In stock | $ 72.00 | |
50 mg | In stock | $ 97.00 | |
100 mg | In stock | $ 155.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 39.00 |
Description | DRB is a nucleoside analog that inhibits several carboxyl-terminal domain (CTD) kinases including casein kinase II (IC50 range of 4-10 μM) |
Targets&IC50 | CTD:4-10 µM |
In vitro | DRB can inhibit HIV transcription (IC50 = ~4 μM) by targeting elongation enhanced by the HIV-encoded transactivator Tat[1]. |
Molecular Weight | 319.14 |
Formula | C12H12Cl2N2O4 |
CAS No. | 53-85-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.19 mg/mL (10 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DRB 53-85-0 Microbiology/Virology Proteases/Proteasome HIV Protease 5,6-Dichlorobenzimidazole riboside inhibit Inhibitor CDK Cyclin dependent kinase inhibitor